Table 3 Medical management within 3 months prior to definitive bowel resection.

From: Risk factors for postoperative surgical site infections in patients with Crohn’s disease receiving definitive bowel resection

 

SSI group (n = 49)

Non-SSI group (n = 105)

p-value

Medications* (n, %)

—

—

ns

5-ASA

31 (63.3%)

68 (64.8%)

—

Corticosteroid

4 (8.2%)

5 (4.8%)

—

AZA/6-MP

5 (10.2%)

12 (11.4%)

—

Tripterygium wilfordii polyglycoside

22 (44.9%)

30 (28.6%)

—

Anti-TNF antibody

3 (6.1%)

8 (7.6%)

—

Preoperative enteral nutrition (n, %)

44 (89.8%)

97 (92.4%)

ns

Preoperative parenteral nutrition (n, %)

32 (65.3%)

72 (68.6%)

ns

Preoperative antibiotics (n, %)

28 (57.1%)

51 (48.6%)

ns

  1. *Since a patient may receive several drugs during this period, the total percentage was more than 100%. Abbreviations: ns, not significant; 5-ASA, 5-amino salicylic acid (mainly includes sulfasalazine and mesalazine); AZA/6-MP, azathioprine/6-mercaptopurine.
Back to article page